June 7, 2020

New Investigator Competition

Hear Shock’s New Investigators present their amazing science. These finalists were selected by the Awards and Honors Committee, based on scientific merit of the submitted abstracts. Finalists will present their work in a 10-minute presentation followed by a 5-minute Q&A period from the Awards and Honors Committee members.


June 8, 2020

Views from the NIGMS, Including the Sepsis Research Priorities

During this webinar, you will learn about the recommendations of the Working Group on Sepsis convened by NIGMS. The group will discuss the NIGMS Priorities for Sepsis Research and how they will be implemented. You will also learn more about the Request for Information on the Strategies to Support Acquisition and Use of Biospecimens for Research on Sepsis in Humans.

Speakers:
Sarah E. Dunsmore, Ph.D., Program Director, NIGMS, NIH
Rochelle M. Long, Ph.D., Division Director, NIGMS, NIH
Xiaoli Zhao, Ph.D., Program Director, NIGMS, NIH 


June 9, 2020

Your Society’s Town Hall
This is your chance to ask what you have always wanted to know and to get to know the officers of your Society.

Panelists:
Marc Jeschke, MD, Ph.D., Surgeon-Scientist and Professor, Department of Surgery and Immunology, University of Toronto
Laurie Kilpatrick, Ph.D., Professor of Physiology, Department of Thoracic Medicine and Surgery, Temple University
Melanie Scott, MD, Ph.D., Associate Professor of Surgery, Department of Surgery, University of Pittsburgh
Irshad Chaudry, Ph.D., Professor, Department of Surgery, Microbiology, Cell, Developmental and Integrative Biology, University of Alabama at Birmingham
Philip Efron, MD, Professor of Surgery and Anesthesiology, University of Florida College of Medicine
Serena G. Weisman, CAE, Executive Director, Shock Society

Battles and Successes in the Beginning of Your Career: Tackling the K award
The Shock Society is excited to present a panel of early-stage investigators that have K award funding to learn about the battles and successes in their academic careers thus far. They will tackle how to secure K funding while at a small institution, the experience and advice they received that influenced their ability to get funded, and the values and failures of finding additional funding while being a K awardee. Each panelist will highlight their work in a 10-minute presentation, followed by a 30-minute Q&A session.

Speakers:
Vanessa Nomellini, MD, Ph.D., Assistant Professor of Surgery, University of Cincinnati 
Lucy Z. Kornblith, MD, Assistant Professor, Division of General Surgery , University of California San Francisco
Jon D. Simmons, MD, Associate Professor, Department of Surgery, University of South Alabama


December 17, 2020

Rethinking Sepsis: The Odyssey Continues
by Dr. John Marshall

Dr. John Marshall is a Professor of Surgery at the University of Toronto, and a Trauma Surgeon and Intensivist at St. Michael’s Hospital in Toronto, Canada.  His academic interests are sepsis, trauma, and the innate immune response.  His laboratory studies the cellular mechanisms that prolong neutrophil survival in critical illness by preventing neutrophil programmed cell death, or apoptosis.  Professor Marshall has an active clinical research interest in sepsis and Intensive Care Unit-acquired infection, and in the design of clinical trials and outcome measures.  He has published 315 manuscripts, and 80 book chapters, and is the editor of 2 books.  He is the founding chair of the International Forum of Acute Care Trialists (InFACT) – a global network of investigator-led critical care clinical research groups, Secretary-General of the World Federation of Societies of Intensive and Critical Care Medicine, and vice-chair of the International Severe Acute Respiratory Infections Consortium.  He is past-chair of the International Sepsis Forum, past-President of the Surgical Infection Society, and past-chair of the Canadian Critical Care Trials Group.  He has given invited lectures at more than 460 meetings around the world, and is a member of the editorial boards of seven journals.


January 12, 2021

Updates in Molecular Phenotyping of ARDS
by Dr. Carolyn Calfee, MD
 

Carolyn S. Calfee, MD MAS is Professor of Medicine and Anesthesia at the University of California, San Francisco, where she attends in the intensive care units. Her primary academic focus is the pathogenesis and treatment of the acute respiratory distress syndrome (ARDS). Current research projects include: (1) molecular subphenotypes of ARDS and precision medicine in critical care; (2) the role of environmental exposures including smoking, air pollution, and novel tobacco products in susceptibility to lung injury; and (3) novel treatments for ARDS. During the COVID-19 pandemic, she has been the UCSF clinical lead and steering committee member for the NIAID-funded Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) study and she is one of the lead PI’s for the ISPY COVID clinical trial, a Phase 2 adaptive platform clinical trial of novel treatments for COVID-19 associated ARDS.


February 8, 2021

Serendipity, Curiosity, and Dogged Persistence....Research Made Easy
by Dr. Mervyn Singer

Mervyn Singer is Professor of Intensive Care Medicine at University College London, UK. His research focusses primarily on sepsis, tissue oxygenation, shock, and novel monitoring techniques. He was the first intensivist to be awarded Senior Investigator status by the UK National Institute for Health Research, is current Chair of the International Sepsis Forum, co-led the ‘Sepsis-3’ international taskforce (with a certain C Deutschman Esq), and has authored/edited various textbooks including the Oxford Handbook of Critical Care and Oxford Textbook of Critical Care.


March 18, 2021 

Incorporating Microbiome Sciences in Shock-Related Research
by Dr. John C. Alverdy

John Alverdy, MD, FACS, is a leading surgeon-scientist with a focus on the molecular basis of surgical infections and the gut microbiome. Dr. Alverdy is the Sarah and Harold Lincoln Thompson Professor of Surgery and executive vice-chair, department of surgery, University of Chicago, IL. His research has received continuous National Institutes of Health (NIH) funding since 1999, and he has mentored many postdoctoral fellows, surgical trainees, and colleagues. Dr. Alverdy has served in leadership positions at many national organizations. He presented the I.S. Ravdin Lecture in the Basic and Surgical Sciences at the ACS Clinical Congress 2017, and he received the American Surgical Association’s Flance-Karl Award in 2018 for his groundbreaking work in surgical infection pathogenesis and microbiome research.


April 16, 2021

Microcirculatory Dysfunction in Inflammatory Injury
by Sarah Yuan, M.D., Ph.D

Sarah Yuan, M.D., Ph.D., is Professor and Chair of the Department of Molecular Pharmacology and Physiology at University of South Florida Morsani College of Medicine, where she also serves as Professor of Surgery and holds the Deriso Endowed Chair in Cardiovascular Disease. With a training background as a trauma surgeon, Dr. Yuan has been conducting translational research aimed at discovering novel molecular mechanisms underlying system/organ pathophysiology with diagnostic and therapeutic implications. Her work focuses on the cellular and molecular control of microcirculatory function in inflammation. Currently, her laboratory investigates blood and endothelial cell-cell interactions that regulate vascular barrier integrity following trauma and sepsis. Her group is known for their expertise in studying endothelial permeability and developing innovative approaches for integrated analysis of human, animal, and cell models of inflammatory injury. Since 1994, her research has continuously been funded by the NIH, which has not only resulted in many high-impact publications, but also provided numerous training opportunities for physicians and basic scientists across multiple disciplines. The majority of her mentees have successfully advanced in their academic or research careers. Her achievements have been recognized nationwide with a number of prestigious honors and awards, including the Landis Award from the Microcirculatory Society, Fellow of the American Physiology Society, Fellow of American Association for the Advancement of Science, an elected member of Alpha Omega Alpha Honor Medical Society. Most recently, she received the NHLBI Outstanding Investigator Award.

 


May 12, 2021
Prehospital Interventions Following Traumatic Injury: The Early Bird Gets the Worm

by Jason Sperry, M.D., MPH

Dr. Sperry is a Professor of Surgery and Critical Care Medicine, the Section Chief of Trauma and General Surgery and Acute Care Surgery Fellowship Director at the University of Pittsburgh. Dr. Sperry is the Principal Investigator for the LITES network, a multicenter trauma network to execute clinical trials for the Department of Defense. Dr. Sperry is the Principal investigator for the PAMPer trial and STAAMP trials funded by the Prehospital Use of Plasma in Traumatic Hemorrhage (PUPTH) program and the Tranexamic Acid Clinical Research (TACR) program, under the direction of the Department of The ARMY and Principal Investigator for the PPOWER trial, funded by the NHLBI to characterize whole blood resuscitation following injury.